InsiderTrades

Form 4 for CDLX Cardlytics, Inc.

Accepted 2026-07-06 17:52:46 ET · period of report 2026-07-01 · accession 0001628280-26-047392 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-07-06 17:52 2026-07-01 CDLX Gupta Amit CEO, Dir M - OptEx — +31.2K 130.0K +32% —
DM 2026-07-06 17:52 2026-07-02+ CDLX Gupta Amit CEO, Dir S - Sale+OE $4.39 -16.1K 113.8K -12% -$70.9K
DM 2026-07-06 17:52 2026-07-01 CDLX Gupta Amit CEO, Dir M - OptEx $0.00 -31.2K 131.2K -19% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-07-01 M A 12,500 — 111,238 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. (F2) Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.
2 Common Common Stock 2026-07-01 M A 18,750 — 129,988 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
3 Common Common Stock 2026-07-02 S D 6,498 $4.39 123,490 D — — (F3) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.260 to $4.540, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
4 Common Common Stock 2026-07-06 S D 9,640 $4.39 113,850 D — — (F4) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.280 to $4.510, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).
5 Derivative Restricted Stock Units 2026-07-01 M D 12,500 $0.00 37,500 D — · — to — 12,500 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. (F2) Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. (F5) 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. (F5) 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. (F2) Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.
6 Derivative Restricted Stock Units 2026-07-01 M D 18,750 $0.00 131,250 D — · — to — 18,750 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. (F2) Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. (F6) The RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. (F6) The RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. (F2) Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.